New medicines – from development to funding
None of us can have everything we want – our resources only stretch so far.
This is true of healthcare. The budget will never be big enough to cover everyone's preferred medicine or medical device.
In today's world, information about the latest treatment travels fast and often before clinical trials are completed.
When a new medicine becomes available it is often presented as doing the job better than older medicines, but it's not always the case. We assess new treatments and new uses for old treatments, and fund those that make the most improvement to the health of New Zealanders within the funding available.
This section looks at some of the issues that PHARMAC faces when considering the funding of a new medicine:
Last updated: 29 June 2020